Kitasato University   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Tokyo Japan (2008)

Organization Overview

First Clinical Trial
2008
NCT00150670
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Centre for Advanced IBD Research and Treatment, Kitasato Institute Hospital, Kitasato University | East Hospital, Kitasato University | Kitasato University | Kitasato University East Hospital, Kanagawa, Japan | Kitasato University Hospital | Kitasato University Kitasato Institute for Life Sciences | Kitasato University Kitasato Institute Hospital | Kitasato University School of Medicine | Yuji Kumagai | Yuji KUMAGAI